Measurement of antipyrine half-life from urinary drug concentrations

Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance

PURPOSE

Develop a minimal mechanistic model based on in vitro-in vivo extrapolation (IVIVE) principles to predict extent of passive tubular reabsorption. Assess the ability of the model developed to predict extent of passive tubular reabsorption (Freab) and renal excretion clearance (CLR) from in vitro permeability data and tubular physiological parameters.

METHODS

Model system parameters were informed by physiological data collated following extensive literature analysis. A database of clinical CLR was collated for 157 drugs. A subset of 45 drugs was selected for model validation; for those, Caco-2 permeability (Papp) data were measured under pH6.5-7.4 gradient conditions and used to predict Freab and subsequently CLR. An empirical calibration approach was proposed to account for the effect of inter-assay/laboratory variation in Papp on the IVIVE of Freab.

RESULTS

The 5-compartmental model accounted for regional differences in tubular surface area and flow rates and successfully predicted the extent of tubular reabsorption of 45 drugs for which filtration and reabsorption were contributing to renal excretion. Subsequently, predicted CLR was within 3-fold of the observed values for 87% of drugs in this dataset, with an overall gmfe of 1.96. Consideration of the empirical calibration method improved overall prediction of CLR (gmfe=1.73 for 34 drugs in the internal validation dataset), in particular for basic drugs and drugs with low extent of tubular reabsorption.

CONCLUSIONS

The novel 5-compartment model represents an important addition to the IVIVE toolbox for physiologically-based prediction of renal tubular reabsorption and CLR. Physiological basis of the model proposed allows its application in future mechanistic kidney models in preclinical species and human.

Reaction kinetics and transformation of antipyrine chlorination with free chlorine

Chlorine has been documented that it can effectively remove some pharmaceuticals. Recently, new active oxidants chlorine monoxide and molecular chlorine, which exist as free active chlorine in solution, were reported during pharmaceuticals chlorination. In this study, reaction kinetics, active oxidants, and transformation products during antipyrine chlorination were investigated with batch experiments. The reaction orders in [chlorine] were determined at various pH (6.53-7.62) and ranged from 1.13 ± 0.15 to 1.59 ± 0.08, which indicated that antipyrine chlorination is the concurrent existence of reactions appearing first-order and second-order in [chlorine]. The results by varying solution conditions (solution pH, chloride, ionic strength, and buffer concentration) show that chlorine monoxide and molecular chlorine play significant roles during the process of antipyrine chlorination. With kinetics modeling, the second-order rate constants for hypochlorous acid, chlorine monoxide, and molecular chlorine were obtained at 25 ± 2 °C (units: M(-1) s(-1)): kHOCl = 3.23 × 10(3), kCL2 = 2.86 × 10(7), kCL2O= 8.38 × 10(9) (R(2) = 0.9801). At pH 7, hypochlorous acid and chlorine monoxide are the main contributors to the degradation of antipyrine, about 80% and 20%, respectively (calculated by kHOCl, kCL2 and kCL2O. By applying these rate constants to predict the antipyrine elimination in real water matrixes (surface water, ground water), a good agreement was obtained, particularly in ground water. Moreover, liquid chromatography-tandems mass spectrometry (LC-MS/MS) and gas chromatograph-mass spectrometry (GC-MS) were used for products identification. Two main intermediate products and three stable products were observed during the process of antipyrine chlorination. The possible routes for antipyrine chlorination were proposed, which mainly consisted of halogenations, dealkylations and hydroxylations.

Influencing factors and degradation products of antipyrine chlorination in water with free chlorine

Owing to its low cost, free chlorine is one of the most common disinfectants for wastewater and drinking water treatment. However, the formation of disinfection byproducts has been found to occur after free chlorine disinfection in recent decades. Antipyrine (ANT), an anti-inflammatory analgesic, has been frequently detected in the aquatic environment. In this work, the removal efficiency of ANT by free chlorine oxidation in ultrapure water was investigated with batch experiments. The influencing factors on the removal of ANT were explored at initial concentrations of ANT from 0.04 to 0.64 mg/L, free chlorine dosage from 0.30 to 1.31 mg/L, and pH from 1.5 to 9.0. The main degradation products were identified by solid phase extraction-gas chromatography-mass spectrometry. The results showed that ANT reacted rapidly with free chlorine in ultrapure water systems and up to 90.6% removal efficiency of ANT was achieved after 25 sec (initial free chlorine 1 mg/L, ANT 0.5 mg/L, pH 7.0). Higher oxidant dosage, lower ANT initial concentration and low pH favor the ANT removal. The main degradation product in ANT chlorination was a monochlorine substitution product (4-chloro-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one), which can be further chlorinated by free chlorine. In addition, the total organic carbon result indicated that ANT is difficult to be mineralized using chlorine.

Relationship between antipyrine elimination rate constant, clearance and volume of distribution in the rat

While the relationship between the inverse of antipyrine half-life and clearance has been shown to be approximately linear in man, a recent report indicated that there was no significant relationship between antipyrine elimination rate constant (lambda) and clearance (CL) in the rat. Since this relationship is critical to the use of non-invasive methods to estimate drug metabolizing capacity, we have re-examined the relationship between lambda and CL in the rat. A significant correlation (r = 0.887) was found between antipyrine lambda and CL, while only a weak relationship (r = 0.442) was found between lambda and volume of distribution. These data support the use of non-invasive methods to estimate antipyrine elimination in the rat when invasive methods need to be avoided.

Plasma antipyrine half-life can be determined from urine data

Antipyrine half-life has been determined from measurements of antipyrine concentrations in spontaneously voided urine specimens in eleven subjects, studied on a total of forty-seven different occasions while receiving no drugs, interferon or ketoconazole. Plasma and saliva half-lives show good intrasubject correlation. Plasma and urine half-lives show good intrasubject correlation provided total urine output is at least 1.1 l day-1. The range of intrasubject correlation coefficients for plasma and urinary half-lives was 0.76 to 0.98, with a median value of 0.85. Saliva and urine half-lives show good intrasubject correlation, with the range of intrasubject correlation coefficients from 0.74 to 0.98, and with a median value of 0.75. There is a small but consistent bias towards shorter urinary half-life estimates; this averaged 0.75 h for the plasma-urine studies and 0.192 h for the saliva-urine studies. There were parallel changes in antipyrine half-life estimated from plasma and urine for one of our subjects who received multiple doses of recombinant beta-interferon and had a 150% increase in antipyrine half-life over the study period.

Effect of acute and chronic exercise on hepatic drug metabolism

Recent research indicates that physical exercise and fitness are new host factors with impact on hepatic drug metabolism, contributing to the intra- and interindividual variation in drug response. Moderate to heavy physical exercise for a few hours reduces liver blood flow as assessed by indocyanine green clearance, leading to a decreased elimination of drugs exhibiting flow-limited metabolism (high clearance drugs) such as lignocaine (lidocaine). However, hepatic elimination of drugs exhibiting capacity-limited metabolism (low clearance drugs) such as antipyrine (phenazone), diazepam and amylobarbitone (amobarbital) is not affected by acute physical exercise. Improved physical fitness as expressed by the maximum oxygen uptake seems to increase the elimination rate of the low clearance drug antipyrine and possibly also aminopyrine, while investigations of the biotransformation of high clearance drugs are contradictory. The sum of research in this recent field is rather limited and the mechanism whereby changes in physical fitness influence hepatic drug metabolism needs to be established. It is not known if other liver functions are changed. If the findings also apply for drugs with a low therapeutic index, there may be a risk of exercise-induced changes in drug efficacy and toxicity. It is suggested that future studies on host factors influencing drug metabolism should include information on physical activity.